Published byluanne-stotts
Disclaimer Mention of any company or product does not constitute endorsement by the National Institute for Occupational Safety and Health NIOSH In addition citations to Web sites external to NIOSH do not constitute NIOSH endorsement of the sponsorin
Download Pdf - The PPT/PDF document "NIOSH List of Antineoplastic and Other H..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Disclaimer Mention of any company or product does not constitute endorsement by the National Institute for Occupational Safety and Health NIOSH In addition citations to Web sites external to NIOSH do not constitute NIOSH endorsement of the sponsorin ID: 3585 Download Pdf
Are You Prepared?. Alexandra . Sible. , . PharmD. NMPhA. Mid-Winter Meeting. January 28, 2018. Objectives. Upon completion of this activity, participants will be able to…. 1. Describe the background and purpose of USP General Chapters 797 and 800 and explain key differences between the two chapters. .
Patricia C. Kienle, RPh, MPA, FASHP. Director, Accreditation and Medication Safety. Cardinal Health Innovative Delivery Solutions. Disclaimer. Patricia Kienle is an employee of Cardinal Health. She is a member of the USP Compounding Expert Committee, but this presentation is not endorsed by or affiliated with USP.
. the. . Hazards. of Non-. Compliance. Dustin Ezell, . PharmD. , BCPS. Baptist Health – North Little Rock. Learning Objectives. Compare <USP 800> requirements to current guidelines and practices.
Consultation Education and Training Division. Michigan Occupational Safety and Health Administration . www.michigan.gov/miosha. 517-284-7720. Module 2. Before Beginning Module 2. Please review . Module 1.
Consultation Education and Training Division. Michigan Occupational Safety and Health Administration . www.michigan.gov/miosha. 517-284-7720. Module 2. Before Beginning Module 2. Please review . Module 1.
Proposed Rule. October 20, 2015. SBEAP Technical Subcommittee. Outline of Today’s Briefing. 2. Part I: Background. Which Pharmaceuticals are Hazardous Waste?. Flow of Pharmaceuticals & Problem Areas.
Consultation Education and Training Division. Michigan Occupational Safety and Health Administration . www.michigan.gov/miosha. 517-284-7720. Module 1. Module 1 Training Overview. Hazardous drug categories.
Patricia C. Kienle, RPh, MPA, FASHP. Disclosure. Patricia Kienle is a member of the USP Compounding Expert Committee but this talk is not affiliated with nor endorsed by USP. Objectives - Pharmacists.
Consultation Education and Training Division. Michigan Occupational Safety and Health Administration . www.michigan.gov/miosha. 517-284-7720. Module 1. Module 1 Training Overview. Hazardous drug categories.
Seth Eisenberg RN OCN. ®. BTMCN. ®. Comparison: Gloves. NIOSH. Washington State. USP<800>. Double chemotherapy gloves (ASTM rated) for chemotherapy; consider for non-antineoplastic HDs.. Powder-free chemotherapy gloves when handling .
© 2021 docslides.com Inc.
All rights reserved.